Abstract
The natural history of menopause (the cessation of menses) and the climacteric (the period of transition from reproductive to postreproductive status) involves termination of the reproductive and endocrine functions of the ovaries. For many women this period in life is associated with symptoms and complaints.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Utian WH. Overview on menopause. Am J Obstet Gynecol 1987; 156:1280–3.
Mishell DR. Is routine use of estrogen indicated in postmenopausal women? An affirmative view. J Fam Pract 1989; 29:406–9.
Wentz AC. Management of the menopause. In: Jones HW, Wentz AC, Burnett LS, editors. Novak’s textbook of gynecology. 11th ed. Baltimore: Williams & Wilkins, 1988:398–442.
Rebar RW, Spitzer IB. The physiology and measurement of hot flushes. Am J Obstet Gynecol 1987;156:1284–8.
US Preventive Services Task Force. Estrogen prophylaxis. Am Fam Physician 1990;42:1293–6.
Hazzard WR. Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am J Obstet Gynecol 1989;161:1847–53.
Grady D, Rubin SM, Pettiti DB, Fox CS, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 1992;117:1016–37.
Johnston CC, Slemenda CW, Melton LJ III. Clinical use of bone densitometry. N Engl J Med 1991;324:1105–9.
Barrett-Conner E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861–7.
Goldman L, Tosteson ANA. Uncertainty about postmenopausal estrogen: time for action, not debate. N Engl J Med 1991;325: 800–2.
Nabulsi AA, Folsom AR, White A, Patsch W, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069–75.
Martin KA, Freeman MW. Postmenopausal hormone-replacement therapy. N Engl J Med 1993;328:1115–7.
Notelovitz M. Estrogen replacement therapy: indications, contraindications, and agent selection. Am J Obstet Gynecol 1989; 161:1832–41.
Henderson BE, Ross RK, Lobo RA, Pike MC, Mack TM. Reevaluating the role of progestogen therapy after the menopause. Fertil Steril 1988;49:9S-15S.
Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985–90.
Henrich JB. The postmenopausal estrogen/breast cancer controversy. JAMA 1992;268:1900–2.
Barrett-Conner E. Postmenopausal estrogen replacement and breast cancer. N Engl J Med 1989;321:319–20.
American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Int Med 1992;117:1038–41.
Walters M, Realini JP. Diagnosis and management of urinary incontinence in women: a primary care approach. J Am Board Fam Pract 1992;5:289–304.
Cowan BD, Morrison JC. Management of abnormal genital bleeding in girls and women. N Engl J Med 1991;324:1710–5.
Hormone replacement therapy. Technical Bulletin No. 166. Washington, DC: American College of Obstetricians and Gynecologists, 1992.
Weinstein L, Bewtra C, Gallagher JC. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol 1990; 162: 1534–42.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Realini, J.P. (1994). Menopause. In: Taylor, R.B. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4005-9_106
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4005-9_106
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-4007-3
Online ISBN: 978-1-4757-4005-9
eBook Packages: Springer Book Archive